Literature DB >> 4389710

The pharmacolgy of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (ah 3474), a beta-adrenoreceptor blocking agent.

C H Blackburn, L J Byrne, V A Cullum, J B Farmer, G P Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4389710     DOI： 10.1111/j.2042-7158.1969.tb08299.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

Authors:  J Zaagsma; L Meems; M Boorsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  The relation between ionization and affinity of beta-adrenoceptor ligands.

Authors:  A P IJzerman; T Bultsma; H Timmerman; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

3.  Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.

Authors:  B N Singh; E M Williams
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

4.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

5.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

6.  Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.

Authors:  J F Truelove; G R van Petten; R F Willes
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.